pharma · Infertility · Ovarian Cancer · NWBO
NORTHWEST BIOTHERAPEUTICS
NORTHWEST BIOTHERAPEUTICS INC
NORTHWEST BIOTHERAPEUTICS is a pharma organization headquartered in Bethesda, USA. It trades on NYSE under ticker NWBO. Primary therapeutic focus areas include Infertility, Ovarian Cancer, Environmental Exposure, Colorec
4800 Montgomery Lane, Suite 800, Bethesda, MD 28014, US HQ
1998 Founded
20 Employees
Public company Type
NWBO · NYSE Ticker
Company details
- Status
- Public
- HQ
- 4800 Montgomery Lane, Suite 800, Bethesda, MD 28014, US
- Founded
- 1998
- Employees
- 20
- Programs
- 33
- Drugs
- 40
- Patents
- 595
PRODIGE 107-ENGIC01-COLOSOTO
Phase 2 · small molecule · Colorectal Carcinoma
PRODIGE 107-ENGIC01-COLOSOTO for Colorectal Carcinoma is a Phase 2 program (small_molecule) at NORTHWEST BIOTHERAPEUTICS INC with 1 ClinicalTrials.gov record(s).
Internal code PRODIGE 107-ENGIC01-COLOSOTO
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- NORTHWEST BIOTHERAPEUTICS INC
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Colorectal Carcinoma
- Status
- active
- Trials
- 1